Document is current
Any future updates will be listed below
-
Authors
Donadio, V.
Ingelsson, M.
Rizzo, G.
Furia, A.
Incensi, A.
Delprete, C.
Pinho, M.
Liguori, R.
Pritzkow, S.
- License Information
-
More Information
Article History
Received: 5 May 2025
Accepted: 20 November 2025
First Online: 4 December 2025
Declaration
:
: Not applicable.
: SP has a conflict of interest in relation to Amprion, a biotechnology company that focuses on the commercial use of seed amplification assays for high-sensitivity detection of misfolded protein aggregates involved in various neurodegenerative diseases. The University of Texas Health Science Center at Houston has licensed patents and patent applications to Amprion. MI is a paid consultant to BioArctic and Eisai Co.
